SNB-19 In Vivo Tumorigenesis Assay

This assay is to provide SNB-19-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

SNB-19

Human

SNB-19 is a human glioblastoma cell line that was isolated from a left parieto-occipital glioblastoma of a 47-year-old male patient in 1980. In a 1988 study, published in Cancer Research Journal, the SNB-19 cell line was the most clonogenic in soft agar and showed the most tumorigenicity in nude mice.

Glioblastoma

Oncology

In Vivo Tumorigenesis Assay

SNB-19-cell based In Vivo Tumorigenesis Assay

Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.

Oncology In Vivo Assays